Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘china retractions’ Category

Plant scientist logs 4 more notices over figure errors

without comments

Researchers in China have retracted a paper and corrected three others in a plant journal, citing problems with multiple figures.

Lixin Zhang, from the Chinese Academy of Sciences in Beijing, is corresponding author on all four papers, published by Plant PhysiologyWe’ve reported on three retractions and two corrections from Lixin Zhang and some of the same co-authors, bringing Zhang’s total to five retractions and four corrections, by our count.

According to the retraction notice, the authors agreed to pull the article because of figure-related “irregularities and inappropriate data handling” — but despite these issues, they remain confident that their conclusions are still valid.

Here’s the latest retraction notice, issued this February, for “Cooperation of LPA3 and LPA2 Is Essential for Photosystem II Assembly in Arabidopsis:”  Read the rest of this entry »

Physics paper’s results off by factor of 100

without comments

Researchers from China have retracted a physics paper after realizing an error led them to report results that were nearly 100 times too large.

What’s more, the authors omitted key findings that would enable others to reproduce their experiments.

According to the notice, the authors used a value to calculate a feature of electrons—called mobility—that “was approximately 100 times too small,” which led to results that were “100 times too large.” The notice also details several gaps in the presentation of experimental results, which preclude others from duplicating the experiments.

Here’s the retraction notice for “Bulk- and layer-heterojunction phototransistors based on poly[2-methoxy-5-(2′-ethylhexyloxy-p-phenylenevinylene)] and PbS quantum dot hybrids:” Read the rest of this entry »

Why don’t the raw data match what was reported in a chemistry paper?

without comments

Chemistry researchers in China have retracted their 2016 paper after reporting that the raw data did not match what they presented in the article.

The authors were attempting to develop a method to produce large amounts of a high-quality two-dimensional form of antimonene, a prized crystal structure that has been notoriously difficult to synthesize reliably.

They were successful, according to the paper, achieving “a large quantity of few-layer antimonene” and demonstrating its “exact atomical structure” and properties.

But they may have spoken too soon. Read the rest of this entry »

“Knowledgeable informant” outs researchers for falsifying data

with 2 comments

A pathology journal has retracted a 2015 paper from researchers in China after concluding the authors had falsified and copied some of the data and text.

According to the notice, a “knowledgeable informant” told the journal about the overlap and “fraudulent” aspects of the paper, which the editors were able to confirm. The journal retracted the paper last month.

Here’s the retraction notice for “Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice:”

Read the rest of this entry »

Two retracted papers were published behind bosses’ backs

without comments

Researchers have retracted two 2016 papers from the same journal which were published without the permission of the supervising scientists.

According to the retraction notices, the two Applied Materials & Interfaces articles were “published without the full knowledge or consent of the principal investigators” who guided the research, but are not named in the notices.

The papers share the same three authors, listed in the same order. Last author Fangqiong Tang and middle author Laifeng Li are principal investigators in different labs at the Chinese Academy of Sciences in Beijing. First author Nanjing Hao was formerly in Tang’s research group, but is now at Dartmouth College in New Hampshire.

Here’s the retraction notice for “Fabrication of Carbohydrate-Conjugated Fingerprintlike Mesoporous Silica Net for the Targeted Capture of Bacteria,” which was retracted only months after it was published in November 2016: Read the rest of this entry »

Paper quickly retracted after author used another group’s work

without comments

The author of a 2016 paper has agreed to retract it after an investigation revealed that most of the article came from another research group at the same university.

According to the notice, the author based the majority of his paper on results generated by other scientists without their permission.

Here’s the retraction notice for “Controlled synthesis of magnetic block copolymers for anti-microbial purpose,” published in the Journal of Applied Polymer Science in November and retracted in February: Read the rest of this entry »

A “plethora of data errors” prompts authors to retract oncology paper

with one comment

Researchers in China have retracted a 2016 cancer imaging paper because they introduced “a plethora of data errors” while preparing the article for submission.

Although the retraction notice provides no details on what these errors are or how exactly they occurred, it does point the finger at the researchers, explaining that the data errors happened as a result of their “negligence.”

Here’s the 2017 retraction notice for “Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma,” published November 25, 2016 in Oncotarget: Read the rest of this entry »

Written by Victoria Stern

February 15th, 2017 at 11:30 am

Authors pull virus replication paper after they cannot replicate results

without comments

Researchers in China have retracted a 2016 paper exploring the replication behaviors of a retrovirus, after discovering that the key results could not be reproduced — possibly because their cell cultures had been contaminated.

The authors also cite a disagreement with a colleague, who they say contributed to the work but does not want to be listed as an author.

Here’s the retraction notice for “Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7,” published in the International Journal of Molecular Medicine: Read the rest of this entry »

“We made big mistakes:” Gastric paper pulled with unusual notice

without comments

Sometimes we come across a real head-scratcher.

That happened this week, when we saw a retraction notice for a 2015 paper on gastric cancer in the International Journal of Clinical and Experimental Medicine, which only says the authors “made big mistakes” and contains two fairly significant typos.

Although there’s no sign of a retraction on PubMed, the table of contents for the latest issue of the journal lists the retraction — but includes no hyperlink to the notice. The only way to see it is via a Web cached version. Here’s the text:

Read the rest of this entry »

Authors retract two statin papers, one with problems “too extensive to revise”

without comments

Researchers in China have retracted two 2016 papers about the possible use of a cholesterol-lowering agent to treat bleeding on the brain.

One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, and patient enrollment. The notice is signed by first author Hua Liu of the Nanjing Medical University in China.

Liu is also the first author of another recently retracted paper in Frontiers in Neuroscience, pulled for incorrectly categorizing patients.

The JNS retraction notice begins: Read the rest of this entry »